The first fatal e-scooter crash in Denver occurred earlier this week. According to an article from Denverite.com, the crash happened on August 4, 2019.
E-Scooter vs. Vehicle
Police confirmed that the individual Cameron D. Hagan was using a “Lyft rental stand up e-scooter” when the crash occurred with an automobile. Mr. Hagan was not wearing a helmet at the time of the crash. Mr. Hagan was actually cited for being at fault for the accident.
Mr. Hagan, who is originally from Montana, was transported to Denver Health in critical condition. He was pronounced dead on August 9, 2019.
Uptick in Incidents
Since the introduction of e-scooters as another means of getting around Denver, police have seen a significant rise in the number of accidents involving the scooters. According to the article “Denver police reported 51 incidents involving e-scooters between May 25, 2018, to Aug. 6, according to the department. They included 24 incidents involving motor vehicles and 27 incidents they deemed non-traffic accidents which means a motor vehicle was not involved.”
Injured in an E-Scooter Crash?
If you or a loved one has been injured in an electric scooter crash through no fault of their own contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on personal injury for more information.
In today’s world we are surrounded by electronics: computers, smart phones, laptops. Even traditional things such as cigarettes have started to see the rise of e-cigarettes and vapes. Vapes are promoted as a healthier alternative to smoking as they do not contain the same toxic chemicals that cigarettes produce when burned. However, vape products have significant drawbacks that can be just as dangerous as regular cigarettes.
What is vaping?
As stated above, instead of burning tobacco and inhaling it, vaping involves inhaling nicotine that produced from a battery operated vape or e-cigarette. Often times, vape pens can come in popular flavors such as mint, cherry, and even watermelon. Popular vape company JUUL markets a wide variety of vape flavors to their consumers. However it has been noted that vaping also contains other chemicals that have also been proven to be carcinogens. This is especially concerning as JUUL products are known to contain higher levels of nicotine when compared to other vape products.
Just like with regular cigarettes – certain health issues can develop as a result of using vaping products. Lung issues are one of the main problems that can arise with wheezing, shortness of breath, and scarring being some of the symptoms that can pop up as a result of vaping. These can be especially concerning with young adults, as many vape brands like JUUL focus their marketing efforts towards the young adult audience. Other issues such as seizures, heart problems can occur as a result of vape use.
Injured through the use of a JUUL vape product?
If you or a loved one has been injured through the use of JUUL vape products or other e-cigarette product contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on pharmaceuticals for more information.
A motion has been filed in Suffolk Superior Court by Purdue Pharma involving the lawsuit filed against the company by state Attorney General Maura Healy.
Dismiss the Case
The company’s legal counsel filed the motion arguing that the evidence used by AG Healey is “full of hyperbole” according to an article from Legal Scoops. The company also argued that the lawsuit does not represent Purdue Pharma’s role in the opioid crisis in an accurate way, and that the company is taking active measures to resolve the crisis.
Maura Healey filed a lawsuit against the company claiming that they used extreme marketing tactics to push their painkiller OxyContin to medical providers even when they had knowledge of its addictive qualities. She also claims that these tactics are what has fueled the state (and nationwide) opioid crisis.
Pivotal Ruling in OxyContin case
While no ruling has been announced yet, the forthcoming decision by Judge Sanders who is presiding over the case, could potentially affect other lawsuits filed by states going forward. Purdue Pharma is facing a legal tsunami of sorts – 48 states so far have filed lawsuits against the company over the opioid crisis.
Injured by OxyContin or another Bad Drug?
If you or a loved one has been injured through the use of OxyContin or other pharmaceutical drug contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on pharmaceuticals for more information.
The Pennsylvania Supreme Court declined Monday August 5, 2019 to hear an appeal of a Risperdal case involving Johnson & Johnson and an Alabama family according to an article by the Pennsylvania Record. The appeal was made by Johnson & Johnson’s subsidiary Janssen Pharmaceuticals, developers of the Risperdal drug.
With the original lawsuit, the plaintiffs claimed that using the Risperdal drug which is an antipsychotic for their son who has autism, caused him to develop a condition known as gynecomastia where males develop large breasts. Without a surgical procedure (a mastectomy) the condition is permanent.
Johnson & Johnson tried to paint plaintiffs as trying to game the trial system after they switched out a doctor who had given a deposition but was not licensed to practice medicine in Alabama. The legal counsel for the plaintiffs used another doctor during the trial proceedings. However the judge said the pharmaceutical company seemed to be waiting for just the right time to bring the issue up and possibly turn the tide in their favor.
Possible Future Damages
The lawsuit has now been sent back to lower courts to determine if punitive damages are allowed in this case. Johnson & Johnson continue their legal fight, as many other cases involving Risperdal and the development of this condition have been filed by other plaintiffs.
Injured by a Bad Drug?
If you or a loved one has been injured through the use of Risperdal or other pharmaceutical drug contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on pharmaceuticals for more information.
Arizona’s Attorney General is making a Hail Mary play of sorts to the Supreme Court. Unlike many other states who have filed lawsuits against Purdue Pharma for improper and aggressive marketing tactics of their drug OxyContin they say caused and contributed to the opioid crisis, Arizona’s AG is taking a different approach. Mr. Brnovich is appealing to the court, asking them to stop the Sackler family who owns Purdue Pharma from transferring funds from the company to members of the Sackler family.
Mr. Brnovich claims that the Sackler family knows they are on the ropes after being hit with multiple state lawsuits. According to an article posted by Tuscon.com, Brnovich is wanting the company to have funds available by the time Arizona’s lawsuit against the company begins which is currently set for sometime in 2021.
After settling with states back in 2007, Richard Sackler who was president/CEO of Purdue Pharma reportedly sent a memo asking that funds be transferred from the company to members of the Sackler family, in order to insulate themselves during possible future lawsuits. Mr. Brnovich claims “that the transfer of the funds was made with an intent to hinder, delay or defraud present and future creditors or avoid, basically, paying what they knew was going to be owed.”
Multiple Other Lawsuits Over OxyContin to Come
Purdue Pharma recently settled a lawsuit with the state of Oklahoma, but the legal repercussions of the opioid crisis are just getting started. The company faces a multitude of other state lawsuits regarding the marketing tactics and misleading notion of the safety of OxyContin.
Injured by OxyContin or Other Bad Drug?
If you or a loved one has been injured through the use of OxyContin or other bad drug contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on pharmaceuticals for more information.
A California judge is dismissing a case brought by plaintiffs against Johnson & Johnson over their talc products. The claim is that Johnson & Johnson talc products should be labeled as carcinogenic according to the state’s Prop 65 rule. Read on to find out why dismissing the case actually works in the plaintiff’s favor.
Under California state law, Proposition 65 requires businesses to disclose if their products contain the presence of possible carcinogens that can be dangerous to humans.
Strengthening Their Case
Even though the case was dismissed, the plaintiff’s legal counsel filed a motion to voluntarily dismiss the case according to an article by Law.com. This allows for the legal counsel to be able to refile the case in the future and potentially present a stronger argument by adding more defendants to the suit (like Claire’s a popular retail store that was recently found by the FDA to have asbestos present in some of their cosmetic products). As a result, the plaintiffs might find the judge more willing to rule in their favor.
Johnson & Johnson Legal Woes Continue
The pharmaceutical company pushed back against the motion to dismiss the case, arguing that the opposing counsel was trying to stall proceedings of the trial originally set for this coming October 2019. The company also faces multiple other lawsuits claiming that their talc products contain asbestos which causes individuals to develop ovarian cancer and/or mesothelioma. The lawsuits also claim that Johnson & Johnson was aware that their talc was not safe, but hid the knowledge from the public anyway.
Diagnosed with Ovarian Cancer and/or Mesothelioma?
If you or a loved one has been diagnosed with ovarian cancer and/or mesothelioma and have used Johnson & Johnson talcum powder products extensively, contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on ovarian cancer and talcum powder for more information.
Pharmaceutical company Allergan has reached a potential agreement with plaintiffs over issues with their testosterone replacement therapy drug Androderm according to an article written by Elaine Silvestrini of MarketWatch.
The drug is used for a process known as testosterone replacement therapy (or TRT for short). Androderm is a gel product, designed to help men who have low testosterone levels due to certain medical conditions, boost the hormone level in their body. However, the company has been hit with lawsuits claiming that the product causes serious side effects.
The plaintiffs claim that the drug has caused health issues such as blood clots, heart attacks, and even in some cases: death. According to the lawsuit, about 500 claims could potentially be settled if the agreement is made.
More Lawsuits Remain
Other pharmaceutical companies such as AbbVie, and Auxilium Pharmaceuticals also face multiple claims by plaintiffs over the safety of their TRT drugs. AbbVie has also run into trouble with the FTC back in 2014, after it was sued by the commission for using prohibited methods to block consumers from accessing a lower cost version of their TRT drug Androgel.
Injured by a Bad Drug?
If you or a loved one has been injured through the use of a TRT drug or other pharmaceutical product, contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on pharmaceuticals for more information.
A multi car accident over the weekend on Westbound I-70 near Vail Pass left several individuals with injuries. The crash occurred Saturday July 27, 2019 according to ABC Denver 7.
A portion of Westbound I-70 was closed for an extended period of time following the crash. The article notes that the accident involved three vehicles and at least five individuals suffered injuries from the incident. Three of those hurt were children “and one child was flown to Denver in critical condition.”
The cause of the crash is not known at this time. Police are investigating the incident however it is known that one of the vehicles was hauling a camper vehicle at the time of the crash.
Injured in a Motor Vehicle Accident?
If you or a loved one has been injured in a motor vehicle accident contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on motor vehicle accidents for more information.
A serious crash that injured two people occurred earlier this morning Friday July 26, 2019 as reported by Fox 31 Denver.
Speeding a Major Factor
According to the article, the car that caused the accident was travelling “at least 105 miles per hour on E-470 at Chambers Road.” A Colorado State Patrol officer saw the vehicle and attempted to slow down the car by turning on their patrol lights. The vehicle exited E-470 at Dry Creek Road however and hit two cars when the driver failed to yield to other traffic at the intersection. The vehicle also hit an electrical box which cut power to around 1,000 people in the area.
Two individuals were taken to Sky Ridge Medical Center for treatment. The status of their condition is unknown at this time.
The driver and passenger that were in the speeding vehicle escaped the scene on foot. Police are currently looking for the individuals as an investigation gets underway.
Injured in a Motor Vehicle Accident?
If you or a loved one has been injured in a car accident contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on motor vehicle accidents for more information.
The next big hurdle in the Johnson & Johnson talcum powder lawsuits is approaching quickly according to an article by Fierce Pharma. The company is set to try and challenge evidence that will be submitted for trial by the plaintiff’s attorneys.
New Jersey Hearing
At a hearing set for next Monday July 29, 2019 the company will challenge the truthfulness of the evidence being submitted for the trial. This trial involves about 14,200 lawsuits combined together. The plaintiff’s claim that Johnson & Johnson’s talcum powder products caused their diagnosis of ovarian cancer & mesothelioma due to the presence of asbestos in their talc. They also claim that Johnson & Johnson was aware that their talc was not safe, but purposely hid that knowledge from the public.
Loss In Delaware
Johnson & Jonson have been hit with some pretty big verdicts against them in the courtroom. On top of that, the company was recently denied a motion to move all cases to federal court in Delaware, where their talc supplier Imerys Talc America is currently undergoing bankruptcy proceedings. The company is now subject to a criminal investigation by the Department of Justice.
Pivotal Decision for Talc Cases
Monday’s decision can greatly impact the shape of future talc cases moving forward. For now it remains to be seen whether the momentum will continue in favor of the plaintiffs or if there will be a definite shift.
Diagnosed With Ovarian Cancer and/or Mesothelioma?
If you or a loved one has been diagnosed with ovarian cancer and/or mesothelioma and have regularly used Johnson & Johnson baby powder or their other talcum based products, contact our team at (303)-999-9999 or (303)-835-9342 to schedule a free consultation. Click here to view our practice area page on ovarian cancer and talcum powder for more information.